A survey of researchers’ attitudes to preregistration in animal research reveals multiple perceived barriers to adoption Authors: Cristina Priboi, Boris Mayer, Evie Vergauwe, Bernice S. Elger, Hanno Würbel, Roland G Roberts, Roland G Roberts, Roland G Roberts, Roland G Roberts Published: 2026 ABSTRACT Preregistration is arguably one of the most promising and potentially impactful Open Science practices. Defined as the a priori registration of study designs and analysis plans, preregistration has long been established as standard practice in clinical human research and is increasingly taken up in other fields of science. Despite growing evidence suggesting that preregistration can mitigate questionable research practices, and the existence of two platforms targeting animal studies, preregistration has remained uncommon in animal research. In light of a “reproducibility crisis” and calls for more transparency and rigor also in animal research, preregistration represents a potentially promising step forward. However, implementing such policies without understanding their impact carries potential risks. It is, therefore, essential to uncover animal researchers’ perspectives on the strengths, weaknesses, opportunities, and threats of preregistration before advancing its implementation. Here, we addressed this need as part of a comprehensive feasibility project on preregistration of animal experiments in Switzerland, with the aims to: (1) assess animal researchers’ experiences with preregistration; (2) examine their attitudes, subjective norms, perceived behavioral control, intentions, motivations, and perceived obstacles regarding preregistration; (3) explore associations between these psychosocial constructs and relevant background characteristics; (4) identify perceived facilitators and barriers to preregistration; and (5) summarize researchers’ suggestions for improving preregistration. To this end, we conducted a preregistered, cross-sectional online survey among all registered study directors of ongoing animal experiments in Switzerland. Of 1,385 invited study directors, 418 completed the survey (30.2% return rate; 41% female; age M = 47.1, SD = 9.52). Of these, only 10% had preregistered studies before participating in the survey and 39.2% had never even heard of preregistration. Bureaucratic burden (77.6%), time costs (71.4%), and low flexibility (65.7%) were the most common reported barriers to preregistration. On average, participants reported rather unfavorable attitudes towards preregistration, negative subjective norms, relatively low perceived behavioral control, weak intention, and limited motivation to preregister, along with high perceived obstacles. Participants who had never preregistered a study, as well as those with more research experience, had more negative scores on all assessed psychosocial constructs related to preregistration. Our findings offer guidance on promising measures to enhance acceptance of preregistration among animal researchers, including raising awareness, offering education and training, and facilitating the procedure of preregistration. Introduction The scientific community is facing a profound methodological reformation towards Open Science in response to the so-called “reproducibility crisis”. Institutions, funders and journals are implementing policies to enhance rigor, transparency and reproducibility, with the goal of increasing credibility and trust in science. Preregistration is arguably one of the most promising and potentially impactful tools for improving transparency and scientific rigor [1–3]. Defined as the registration of hypotheses, study designs and analysis plans in independent open repositories before data collection or analysis [1,2,4,5], preregistration may reduce questionable research practices such as publication bias, selective reporting, p-hacking, and HARKing, which may help improve the reproducibility of research findings [1–4,6–9]. Although the effects of preregistration have only recently begun to be studied systematically and robust evidence is still scarce, available research from different disciplines provides direct or indirect support for a potential positive impact of preregistration on the reproducibility of research findings [10,11]. Preregistered studies reported fewer statistically significant results, found smaller effect sizes, and described methods in more detail compared to studies that had not been preregistered [6,8,12–17]. The inability to replicate published results, e.g., in cancer research [18], and the low rates of translating preclinical findings to clinical studies [19,20], have led to questions about the rigor and reproducibility of animal research [18,21–23]. This threatens public support for the responsible use of animals in research, which depends not only on the implementation of the 3Rs (replace, reduce, refine [24]) but also on the assumption that such practices will lead to important contributions to science, medical advances, or nature conservation. It has been shown that study protocols and results from many research projects using animals never get published or published in full [25–28]. Furthermore, substantial deficiencies in the use and reporting of measures against risks of bias have been documented [29,30], including in an exemplary study conducted in Switzerland [31,32]. Apart from increasing public doubts about animal research, such questionable research practices can slow down scientific progress, waste animal lives for inconclusive research, and expose participants in clinical trials to unnecessary risks [33–35]. Although study registries tailored to animal research have been established [4,5], the animal research community appears to meet preregistration with reservations [35]. This may be due to a number of reasons, including researchers’ concerns that preregistration would increase administrative burden, that it would stifle creativity and discovery, that others might steal their ideas, or that they would become targets of animal rights activists [17,36–38]. In addition, researchers may not be aware of the possibilities, functioning, and benefits of preregistration [35]. Nevertheless, policies regarding preregistration are already shifting with key stakeholders adopting preregistration standards for animal studies. A report by the Advisory Committee to the Director (ACD) working group on enhancing rigor, transparency, and translatability in animal research commissioned by the US National Institutes of Health has recommended preregistration for animal studies [39], an increasing number of journals are adopting preregistration badges as part of their publication policies [1,8], and a recent call has been made to implement preclinical study preregistration in the animal research community [38]. Despite the growing popularity of preregistration, the relevance, applicability, and implementation of preregistration have not yet been properly analyzed for animal research. There is a risk of changing policies too far or prematurely before the potential costs and benefits for innovation and research quality, and the practical implications of preregistration have been understood by all parties involved. There is, therefore, an urgent need to evaluate the perceived strengths, weaknesses, opportunities, and threats of preregistration in animal research. As part of a project to address these different aspects, we conducted the present survey among all animal study directors registered in Switzerland. The study was informed by Spitzer and Mueller [40], who had investigated attitudes and experiences with preregistration in psychology researchers. Building on their framework, the specific aims of our study were to: assess the experience of animal researchers in Switzerland with study preregistration, assess the experience of animal researchers in Switzerland with study preregistration, examine several psychosocial constructs related to preregistration, including attitudes, subjective norms, perceived behavioral control, intentions, motivations, and perceived obstacles, examine several psychosocial constructs related to preregistration, including attitudes, subjective norms, perceived behavioral control, intentions, motivations, and perceived obstacles, explore associations between these six psychosocial constructs and background characteristics, such as animal researchers’ preregistration experience, animal research experience, gender, field of animal research, and organization of employment, explore associations between these six psychosocial constructs and background characteristics, such as animal researchers’ preregistration experience, animal research experience, gender, field of animal research, and organization of employment, identify perceived barriers and facilitators to preregistration from the perspective of Swiss animal researchers, and identify perceived barriers and facilitators to preregistration from the perspective of Swiss animal researchers, and summarize participants’ suggestions for improving the practice of preregistration in Switzerland. summarize participants’ suggestions for improving the practice of preregistration in Switzerland. We reasoned that achieving these aims is important in view of providing guidance on promising measures to enhance acceptance of preregistration among animal researchers and facilitate its implementation. Materials and methods The aims, design and analysis plan of this study were preregistered during data collection on the Open Science Framework on June 25, 2024 (https://doi.org/10.17605/OSF.IO/CAUFW). All deviations from the preregistered plan are described following Willroth and Atherton [41] and can be found in the supplementary material (S1 Table). Study design This cross-sectional study received ethical approval from the Ethical Commission of the Faculty of Human Sciences at the University of Bern, Switzerland (Nr. 2024-03-06). All participants provided written informed consent prior to participation. Sample The study sample included researchers accredited as “study directors” of animal experiments under Swiss law. In Switzerland, all animal experiments must be authorized by the competent authority (usually the cantonal veterinary office), and applications for a license to conduct an animal experiment must be submitted through the federal platform animex-ch (https://www.blv.admin.ch/blv/en/home/tiere/tierversuche/forschende/animex-ch.html). According to Swiss animal welfare legislation (TSchV Art. 131), study directors are responsible for designing and conducting animal experiments in compliance with the national and cantonal legal requirements. To qualify as a study director, researchers need to hold a biomedical university degree, have at least three years of experience with animal experimentation, and complete specific additional education and training. Although the role of “study director” is a legal designation, it largely overlaps with the role of “principal investigator”. Our decision to sample participants for this study from the population of study directors was based on the fact that they are usually the ones who decide whether or not to preregister a study. Since other personnel involved in animal experiments (e.g., animal care staff, attending veterinarians, technicians, and students) might have somewhat different views, our findings do not necessarily generalize to all animal researchers. Only researchers who held an active animal research license and were registered as study directors or deputy study directors at the time of recruitment were eligible to participate. Procedure and data collection Data collection was conducted with the support of the Federal Food Safety and Veterinary Office (FSVO) in Switzerland and took place between 29.05.2024 and 26.06.2024. The FSVO, which holds contact information for all registered study directors and deputy study directors in the country, sent an official invitation email with the survey link to all eligible study directors. Two further reminders were sent by the FSVO, seven and 14 days after the initial invitation email. Additionally, one more reminder was issued at the institutional level by the Animal Welfare Officers (AWO). In Switzerland, every institution conducting animal research is obliged by law to have one or more AWO, whose role, as defined by the Animal Welfare Ordinance, is to ensure that applications for animal experiments are complete and coherent, particularly regarding the justification of the experiment’s indispensability, defined endpoints and harm-reduction measures, and the harm–benefit analysis. Our study was discussed within the national AWO network, and all AWO agreed to disseminate an additional reminder at the institutional level within their respective institutions. We provided them with a standard text for their email reminder to ensure consistent wording across institutions. We did not verify whether all AWO complied with this agreement, but we had no reason to doubt it. We, therefore, consider the risk of systematic bias introduced by this reminder to be negligible. Questionnaires Participants completed an online survey in English that included both closed-ended and open-ended items. The items were adapted from the questionnaire developed by Spitzer and Mueller [40] and modified to align with the field of animal research and the study’s research questions. An overview of the specific changes can be consulted in the supplementary material (S1 File). The online survey collected information related to study preregistration, such as participants’ experience with preregistration, their attitudes, subjective norms, perceived behavioral control, intentions, motivations, obstacles, facilitators, barriers, and suggestions for improving preregistration, as well as socio-demographic characteristics. Socio-demographic characteristics. The following demographic variables were collected from the sample: age, gender, years registered as study directors, years of animal research experience, academic age, educational attainment, seniority level, organization of employment, and field of animal research. General experiences. Between three and seven closed-ended items, depending on whether participants had ever preregistered a study or not, were used to assess participants’ general practices and their experiences with study preregistration (S1 File). Psychosocial constructs. The survey included six Preregistration Scales, each evaluating one of the following six psychosocial constructs related to preregistration: attitudes (23 items); subjective norms (7 items); perceived behavioral control (7 items); intentions (3 items); motivations (10 items); and obstacles (10 items). These constructs were primarily derived from the Theory of Planned Behavior (attitudes, subjective norms, perceived behavioral control, and intentions), supplemented by closely related motivational components (motivations and obstacles) [42–44]. The attitudes scale measured participants’ evaluations of and opinions toward the concept of preregistration. The attitudes scale measured participants’ evaluations of and opinions toward the concept of preregistration. The subjective norms scale explored the social pressure and expectations perceived by participants regarding preregistering their studies. The subjective norms scale explored the social pressure and expectations perceived by participants regarding preregistering their studies. The perceived behavioral control scale assessed participants’ judgment of their own ability and confidence to preregister studies. The perceived behavioral control scale assessed participants’ judgment of their own ability and confidence to preregister studies. The intentions scale evaluated the determination to preregister future studies. The intentions scale evaluated the determination to preregister future studies. The motivations scale focused on understanding the rationales behind researchers’ decisions to preregister or not preregister their studies. The motivations scale focused on understanding the rationales behind researchers’ decisions to preregister or not preregister their studies. The obstacles scale measured challenges perceived by researchers in the preregistration process and was conceptualized as part of the psychosocial framework because obstacles capture researchers’ subjective evaluations rather than objective constraints. The obstacles scale measured challenges perceived by researchers in the preregistration process and was conceptualized as part of the psychosocial framework because obstacles capture researchers’ subjective evaluations rather than objective constraints. A detailed description of the items for each scale is provided in the supplementary material (S1 File). All items were closed-ended and were assessed on a 7-point Likert scale ranging from 1 to 7. The values were re-coded from the original scale to a scale centered around 0 ranging from −3 to +3. Barriers and facilitators. The number and wording of items addressing barriers and facilitators of preregistration varied depending on whether participants had previously preregistered a study or not (S1 File). Barriers were assessed with one closed-ended item and up to four open-ended items (“What do you perceive as drawbacks of preregistration?”; “What do you think would be the long-term negative consequences of mandatory preregistration?”; “What are the reasons for not preregistering your studies?”; “I am now less motivated to preregister than I was before because____”). Facilitators were examined exclusively with open-ended items (“What do you perceive as benefits of preregistration?”; “What do you think would be the long-term benefits of mandatory preregistration?”; “I am now more motivated to preregister than I was before because____”). Suggestions. The following open-ended items were used to collect suggestions for improving preregistration of animal experiments in Switzerland: “We are interested in how we can improve various aspects of preregistration (e.g., templates, repositories, reviewing process, integrations in published articles, education, etc.). Do you have any suggestions? What do you think should be improved about preregistration?”; “What would make you (and perhaps other researchers) preregister more often?”; “Do you have any suggestions as to how to lower your (or other researchers’) negative perceptions of preregistration?”. Data analysis Sample description. Descriptive statistics are reported to summarize the socio-demographic characteristics of the study participants. To assess comparability between participants and non-participants, we used an equivalence-based approach. Specifically, we examined whether 90% confidence intervals of effect sizes fell within predefined bounds of negligible effects, corresponding to a two one-sided tests (TOST) framework. For categorical variables, equivalence was defined as |φ| < 0.1, and for continuous variables as |d| < 0.2, reflecting conventional thresholds for small effects [45]. Confidence intervals entirely within these bounds were interpreted as evidence of practical equivalence. The following information regarding non-participants was provided by the FSVO: the total number of eligible study directors invited to participate, and, separately for participants and non-participants, their age (range, median, mean, and standard deviation), gender (number and percentage of female and male participants), and years since their registration as study directors (range, median, mean, and standard deviation). Due to differences in the operationalization of the gender variable and to ensure comparability with FSVO data, the survey responses were re-coded prior to analysis. The FSVO used two categories (“female” and “male”), while our survey included four options (“female”, “male”, “other”, and “prefer not to say”). For consistency, responses coded as “other” and “prefer not to say” were treated as missing in the comparative analysis. The values made available by the FSVO enabled comparisons between participants and non-participants with respect to age, gender, and years since registration as study directors. General experiences (Aim 1). Descriptive statistics were calculated and reported for each item assessing participants’ general experiences with preregistration. In addition, participants with and without preregistration experience were compared across all socio-demographic characteristics. Independent samples t-tests were used to analyze mean differences in continuous variables, while percentage differences in categorical variables were tested using Fisher’s Exact Test. Psychosocial constructs (Aim 2). Psychometric quality: The items of the scales used in the survey were adapted from a questionnaire developed by Spitzer and Mueller [40], who reported high reliabilities for all six Preregistration Scales. However, it remained unclear whether these scales were truly unidimensional. Therefore, we performed principal component analyses (PCA) to explore the dimensional structure of the items within each of the six scales. To determine the appropriate number of components, we applied parallel analysis, using the mean eigenvalues of 1,000 randomly generated samples for comparison. In addition, we used a criterion based on the ratio of the first and second eigenvalue of the PCA (ratios > 3) [46], as well as omega hierarchical (ωH) from a bifactor model (values ≥ .70) [47–49], to assess essential unidimensionality (S2 File). Essential unidimensionality refers to the existence of a dominant general component with the simultaneous presence of subdimensions. If more than one component was identified for a specific scale after applying these criteria, the extraction was followed by an oblique Oblimin-rotation to arrive at a simple structure even when components were correlated. Subsequently, we calculated McDonald’s omega to assess the internal consistency of each scale (or subscale—in case of more than one dimension obtained in the PCA for a specific scale). Item selection was based on factor loadings, corrected item-total correlations, and conceptual alignment. Overview of scales: Descriptive results are reported for each of the six Preregistration Scales (attitudes, subjective norms, perceived behavioral control, intentions, motivations, obstacles). Association analysis (Aim 3). A multivariate analysis of covariance (MANCOVA) was conducted to examine the overall associations of several predictors with the Preregistration Scales and potential Subscales, which served as the outcome variables. The predictors included in the multivariate model were: preregistration experience (“preregistered at least one study”, “never preregister a study”), animal research experience (in years), gender (“female”, “male”), field of animal research (“basic biological research”, “general biology”, “basic and experimental medical research”), and organization of employment (“academia”, “private sector”, “other”). Due to the very low frequency of responses in the gender categories “other” (n = 1) and “prefer not to say” (n = 14), these responses were re-coded as missing prior to analysis. Wilks’ Lambda was used to test the overall multivariate effects of the MANCOVA model for each predictor variable. Pillai’s Trace was additionally computed as a robustness check to verify the stability of the results, given its greater resistance to violations of MANCOVA assumptions. If a significant multivariate effect was detected, follow-up univariate analyses of covariance (ANCOVAs) were performed for each outcome separately to identify which predictors were significantly associated with which outcome. Because the univariate follow-up involved testing the same predictor across multiple outcomes, we controlled the familywise error rate within each predictor by applying a Holm correction across the univariate p-values corresponding to that predictor. Partial eta-squared (ηp2) was computed for each predictor within each outcome to estimate the effect sizes in the univariate models. Values of 0.01, 0.06, and 0.14 for ηp2 were considered small, medium and large [50]. For categorical predictors with more than two levels (i.e., field of animal research and organization of employment), post-hoc pairwise comparisons were conducted only for those outcomes for which the predictor remained statistically significant after Holm correction. Post-hoc tests were based on estimated marginal means (adjusted for all other predictors in the model), with Tukey’s correction applied to pairwise comparisons within each outcome. Thematic analysis (Aims 4 and 5). The answers provided to the qualitative open-ended items were analyzed using inductive thematic analysis [51,52]. Initial coding was conducted by one researcher (CP), followed by discussing the resulting codes and preliminary categories with a second researcher (HW). Codes were subsequently grouped into higher-order categories reflecting facilitators, barriers, and suggestions for improving preregistration. Recurring themes were identified and described within each category. The coding framework was refined iteratively, and differences in interpretation between researchers were resolved by consensus. Example quotations are presented to illustrate each theme. Results Sample description The FSVO identified 1,428 eligible study directors and invited them via email to take part in the online survey. Each study director was provided with a unique access code required to enter the survey. Forty-three emails bounced back, resulting in 1,385 successfully reached study directors. Of these, 744 individuals clicked on the survey link. However, 58 did not enter an access code, 59 entered an incorrect code, and 106 either failed to check the consent box or explicitly declined consent, preventing them from proceeding. Additionally, 17 access codes were used to complete the questionnaire twice, and 2 codes were used three times. In such cases, only the first completed attempt was kept, and subsequent entries were deleted. Three additional cases were removed at the request of the participants. After these exclusions, 497 valid entries remained. A further 17 cases were excluded due to over 90% missing data, and 62 for failing the attention check item (S1 Fig). A final sample of N = 418 participants was included in the analysis, resulting in a response rate of 30.2% among the reached population. Socio-demographic characteristics. Participants were on average 47 years old, and slightly less than half identified as female (Table 1). They had been registered as study directors for about 13 years and had worked in animal research for about 20 years. The majority were highly educated, with over 90% reporting a PhD, Dr. med. or higher, and 60% occupying senior positions such as group leader or professor. The predominant research field was basic and experimental medical research, and most participants were employed in academia. 10.1371/journal.pbio.3003511.t001Table 1Sample description.CharacteristicsParticipants(n = 418)Non-participants(n = 1,010)Total(N = 1,428) Age a M (SD)47.1 (9.52)47.9 (9.65)47.8 (9.60) Mdn46.047.047.0 Range24–8427–9424–94 n418 (0 missing)943 (67 missing)1,361 (67 missing) Gender b Female41.0% (170)44.0% (276)– Male55.4% (230)56.0% (352)– Other0.2% (1)–– Prefer not to say3.4% (14)–– n400 (18 missing)628 (382 missing)– Years registered as study director c M (SD)12.6 (5.86)12.8 (5.86)12.8 (5.86) Mdn12.713.313.3 Range0.2–28.40.3–26.20.2–28.4 N418 (0 missing)1,010 (0 missing)1,428 (0 missing) Animal research experience M (SD)20.1 (8.83)–– Mdn19.0–– Range2–44–– n414 (4 missing)–– Academic age M (SD)17.3 (9.32)–– Mdn16.0–– Range0–40–– n408 (10 missing) Educational attainment Master’s degree5.3% (22)–– PhD/Dr. med.51.6% (214)–– Habilitation/professorship41.9% (174)–– Other1.2% (5)–– n415 (3 missing)–– Seniority level PhD student/technician3.9% (16)–– Postdoc./senior researcher26.6% (110)–– Lecturer2.7% (11)–– Group leader/Professor60.0% (248)–– Other6.8% (28)–– n413 (5 missing)–– Field of animal research Basic and experimental medical researchd72.6% (302)–– General biologye13.9% (58)–– Basic biological researchf13.5% (56)–– n416 (2 missing)–– Organization of employment Academia77.6% (323)–– Academia and other2.1% (9)–– Private sector13.7% (57)–– Governmental2.6% (11)–– Non-profit3.8% (16)–– n416 (2 missing)––Note. M, mean; SD, standard deviation; Mdn, median; n, subgroup sample size; N, total sample size.aThe values for both participants and non-participants were provided by the Swiss Federal Food Safety and Veterinary Office (FSVO). FSVO calculated age using exact birthdates (day, month, year), whereas our survey asked only for the year of birth to protect confidentiality. Therefore, to ensure comparability, FSVO-provided age values are presented. The mean age of participants calculated from the survey data was nearly identical to the FSVO value (M = 46.9, SD = 9.20).bThe values for non-participants are FSVO-provided data, whereas those for participants are based on survey responses. This distinction arises because FSVO collected gender data using only two categories (female, male), while our survey allowed for four options (female, male, other, and prefer not to say).cThe values for both participants and non-participants are FSVO-provided data. They are reported instead of the survey data for participants because the FSVO dataset contained no missing values for this variable.dIncluding following fields: Biomedical Engineering; Cancer Research; Cardiovascular Research; Endocrinology; Immunology; Medical Microbiology; Neuroscience; Nutrition and Metabolism; Pathology and/or Pathophysiology; Pharmacology; Physiology; Regenerative Medicine; Toxicology; Veterinary Medicine; Virology.eIncluding following fields: Animal Breeding; Animal Nutrition; Animal Welfare; Ecology; Ethology; Evolution; Laboratory Animal Science; Wildlife Biology; Zoology.fIncluding following fields: Biochemistry; Biophysics; Cell Biology; Cytology; Developmental Biology; Embryology; Epigenetics; Experimental Microbiology; Genetics; Molecular Biology; Radiobiology; Structural Biology. Sample description. Note. M, mean; SD, standard deviation; Mdn, median; n, subgroup sample size; N, total sample size. aThe values for both participants and non-participants were provided by the Swiss Federal Food Safety and Veterinary Office (FSVO). FSVO calculated age using exact birthdates (day, month, year), whereas our survey asked only for the year of birth to protect confidentiality. Therefore, to ensure comparability, FSVO-provided age values are presented. The mean age of participants calculated from the survey data was nearly identical to the FSVO value (M = 46.9, SD = 9.20). bThe values for non-participants are FSVO-provided data, whereas those for participants are based on survey responses. This distinction arises because FSVO collected gender data using only two categories (female, male), while our survey allowed for four options (female, male, other, and prefer not to say). cThe values for both participants and non-participants are FSVO-provided data. They are reported instead of the survey data for participants because the FSVO dataset contained no missing values for this variable. dIncluding following fields: Biomedical Engineering; Cancer Research; Cardiovascular Research; Endocrinology; Immunology; Medical Microbiology; Neuroscience; Nutrition and Metabolism; Pathology and/or Pathophysiology; Pharmacology; Physiology; Regenerative Medicine; Toxicology; Veterinary Medicine; Virology. eIncluding following fields: Animal Breeding; Animal Nutrition; Animal Welfare; Ecology; Ethology; Evolution; Laboratory Animal Science; Wildlife Biology; Zoology. fIncluding following fields: Biochemistry; Biophysics; Cell Biology; Cytology; Developmental Biology; Embryology; Epigenetics; Experimental Microbiology; Genetics; Molecular Biology; Radiobiology; Structural Biology. To assess whether the two samples can be considered equivalent, we examined 90% confidence intervals (CIs) of effect sizes. For gender distribution, the 90% CI of the φ-coefficient (φ = −0.01, 90% CI [−0.07, 0.04]) fell entirely within the bounds of a small effect (|φ| < 0.1), indicating equivalence. Similarly, for age (d = −0.08, 90% CI [−0.18, 0.01]) and years registered as study director (d = −0.03, 90% CI [−0.13, 0.06]), the confidence intervals were fully contained within the range of negligible effects (|d| < 0.2). These findings suggest that any differences between participants and non-participants are unlikely to represent effective selection biases. General experiences (Aim 1) Only 10.0% (n = 42) of the total sample reported having previously preregistered at least one study, while 90.0% (n = 376) had never done so (S2 Table). Overall, 39.2% (n = 147) of participants had never heard of preregistration prior to this survey, while 31.5% (n = 118) had read about it, and 27.2% (n = 102) had learned about it during further education (S2 Table). Institutional policies were most frequently chosen as influencing the decision whether or not to preregister (47.6%, n = 175), followed by funding guidelines (35.6%, n = 131), superior(s) (32.6%, n = 120), and journal guidelines (26.4%, n = 97). Notably, 28.0% of participants (n = 103) indicated that nobody has an influence on their decision (S2 Table). Participants with preregistration experience had a median of 3 preregistered studies (range 1–80), with an estimated median time of 11 hours per preregistered study (range 1–150) (S2 Table). Comparing the socio-demographic characteristics of participants with and without preregistration experience revealed no statistically significant differences between these two groups (S3 Table). Psychosocial constructs (Aim 2) Psychometric quality. The dimensionality and internal consistency of all preregistration scales was assessed using PCA together with further criteria to assess essential unidimensionality, and McDonald’s omega. When necessary, items with poor psychometric properties (low factor loadings and/or low corrected item-total correlations) and weak conceptual alignment were removed, resulting in improved internal consistency and construct validity of each scale. Specifically, Items 9 and 21 were removed from the Attitudes Scale, and Item 2 was removed from the Subjective Norms Scale due to poor psychometric performance and weak conceptual alignment. No further items were removed from the remaining scales (S2 File). The Preregistration Scales for Attitudes, Subjective Norms, Intentions, and Motivations showed clear unidimensional structures and good to excellent reliability (ω = .84 to ω = .96). In contrast, the Perceived Behavioral Control Scale and the Obstacles Scale revealed a two-component structure and were therefore each divided into two subscales. The Perceived Behavioral Control Scale was separated into: the Perceived Behavioral Control – Resources Subscale (ω = .72), reflecting resources and support for preregistration from colleagues and supervisors; and the Perceived Behavioral Control – Knowledge Subscale (ω = .65), reflecting the knowledge required and authority to decide about preregistration. Similarly, the Obstacles Scale was structured into: the Practical Obstacles Subscale (ω = .84), reflecting perceived disadvantages in terms of time and effort; and the Competitive Obstacles Subscale (ω = .66), describing concerns about scooping and competitive challenges. For detailed results of these analyses, see S2 File. Overview of scales. Based on the psychometric analysis, the following Preregistration Scales and Subscales were used as outcomes in all subsequent analyses: attitudes scale (21 items), subjective norms scale (6 items), perceived behavioral control – resources subscale (4 items), perceived behavioral control – knowledge subscale (3 items), intentions scale (3 items), motivations scale (10 items), practical obstacles subscale (6 items), and competitive obstacles subscale (4 items). Descriptive statistics of all Preregistration Scales and Subscales are presented in Table 2. Across the entire sample, participants reported slightly negative attitudes toward preregistration, moderately negative subjective norms, and slightly negative perceived behavioral control on both subscales. Similarly, both their intentions and motivations to preregister were slightly negative. In contrast, practical obstacles were perceived as moderately higher, and competitive obstacles slightly higher than neutral, indicating that many participants perceived substantial barriers to preregistration. However, on all scales and subscales, participants’ ratings ranged from very low (−2.2 to −3.0) to very high (+1.8 to +3.0) (Table 2). 10.1371/journal.pbio.3003511.t002Table 2Overview preregistration scales.ScalesTotal participants (N = 418) Attitudes Scale M (SD)−0.9 (1.22) Mdn−0.8 Range[−3.0; +2.2] N371 (47 missing) Subjective Norms Scale M (SD)−1.6 (1.00) Mdn−1.7 Range[−3.0; +1.8] N353 (65 missing) Perceived Behavioral Control Resources Subscale M (SD)−0.7 (1.06) Mdn−0.8 Range[−3.0; +2.2] N351 (67 missing) Knowledge Subscale M (SD)−0.4 (1.30) Mdn−0.8 Range[−3.0; +3.0] N351 (67 missing) Intentions Scale M (SD)−0.8 (1.65) Mdn−0.7 Range[−3.0; +3.0] N349 (69 missing) Motivations Scale M (SD)−0.8 (1.36) Mdn−0.8 Range[−3.0; +2.2] N348 (70 missing) Obstacles Practical Obstacles Subscales M (SD)1.5 (1.04) Mdn1.7 Range[−2.2; +3.0] N348 (70 missing) Competitive Obstacles Subscales M (SD)0.7 (1.05) Mdn0.8 Range[−2.5; +3.0] N348 (70 missing)Note. M, mean; SD, standard deviation; Mdn, median; N, total sample size. Overview preregistration scales. Note. M, mean; SD, standard deviation; Mdn, median; N, total sample size. Association analysis (Aim 3) Analyses were performed on complete cases (n = 329). A MANCOVA was conducted to examine the associations of preregistration experience, animal research experience, gender, field of research, and organization of employment with the eight Preregistration Scales and Subscales. All predictors were entered simultaneously, so that each effect reflects the unique association of that predictor with the combined outcome variables, controlling for the other predictors. The multivariate model revealed statistically significant associations for all predictors, namely preregistration experience, animal research experience, gender, field of research, and organization of employment (S4 Table). Fig 1 provides an overview of the strength of these associations across predictors and outcomes based on eta-squared values from the follow-up univariate models. Preregistration experience was most strongly associated with Preregistration Scales and Subscales, followed by animal research experience and field of animal research, while organization of employment and gender showed comparatively weaker associations (Fig 1). Strength of associations between predictors and outcomes. PBC, Perceived Behavioral Control. Cell color indicates partial ηp2 estimates from univariate ANCOVAs adjusted for all other predictors in the model. The data and code required to generate this figure can be found at https://doi.org/10.48620/98470. Preregistration experience. The univariate ANCOVAs (Holm-corrected) showed that participants with preregistration experience had more favorable attitudes, higher subjective norms, greater perceived behavioral control regarding both resources and knowledge, higher intentions, higher motivations, and fewer perceived practical obstacles than those without preregistration experience, while no significant difference between the two groups was found for perceived competitive obstacles (Fig 2A and S4 Table). The corresponding effect sizes were mostly small to medium in magnitude (ηp2 ≈ .03−.07). Associations across predictors and outcomes. (A) Adjusted means by preregistration experience. (B) Adjusted associations by years of animal research experience. (C) Adjusted means by gender. (D) Adjusted means by field of animal research. (E) Adjusted means by organization of employment. Note. PBC, Perceived Behavioral Control. Points in A, C, D, E represent adjusted estimated marginal means controlling for the remaining predictors and error bars indicate 95% confidence intervals. Lines in B represent adjusted predicted values across years of animal research experience, controlling for the remaining predictors, and shaded areas indicate 95% confidence intervals. The data and code required to generate these figures can be found at https://doi.org/10.48620/98470. Animal research experience. By contrast, greater experience in animal research was negatively associated with several Scales and Subscales in the univariate ANCOVAs, although effect sizes were rather small (ηp2 ≈ .04−.05). Specifically, more years of research experience was associated with less favorable attitudes, lower intentions, and lower motivations to preregister (Fig 2B and S4 Table). No significant associations were observed for remaining Scales and Subscales (S4 Table). Gender. The univariate analyses further showed differences between genders, with women reporting moderately lower perceived behavioral control—knowledge compared to men, while no significant gender differences were detected for all other Scales and Subscales (Fig 2C and S4 Table). The corresponding effect size was in the small-to-moderate range (ηp2 ≈ .05), indicating a modest difference rather than a pronounced gender effect (S4 Table). Field of research. Univariate ANCOVAs also revealed differences across participants’ field of animal research in attitudes, motivations, and competitive obstacles (Fig 2D and S4 Table). Post hoc Tukey pairwise comparisons showed that participants working in General Biology reported more positive attitudes towards preregistration, higher motivations to preregister, and lower perceived competitive obstacles compared to those in Basic Biological Research or Basic and Experimental Medical Research. Effect sizes were small (ηp2 ≈ .03−.04), indicating modest differences, and no further significant differences were observed for the remaining outcomes (S4 Table). Organization of employment. With respect to the participants’ employer, a slight to moderate difference was found for perceived behavioral control—knowledge (ηp2 ≈ .05) (Fig 2E and S4 Table). Post hoc Tukey pairwise comparisons revealed that participants working in academia rated their knowledge about preregistration higher than those working in the private sector. No additional significant associations were observed for the remaining Scales and Subscales (S4 Table). Thematic analysis (Aims 4 and 5) A total of 334 participants responded to at least one open-ended item addressing barriers, facilitators, or suggestions for improving preregistration. Of these, 321 had no preregistration experience, while 13 had preregistered at least once prior to data collection. Given the small number of participants with preregistration experience, the uneven distribution of responses across participant characteristics, and the generally brief nature of the open-ended responses, subgroup analyses (e.g., by preregistration experience or other background characteristics) would not have been meaningful. Accordingly, the thematic analysis presented below primarily reflects the views of participants without preregistration experience. An overview of the qualitative codes, including the number of participants who mentioned each code at least once, is provided in S5–S7 Table. Barriers (Aim 4). Responses to open-ended questions on preregistration barriers were provided by up to 313 participants (S5 Table). The thematic analysis of these responses revealed four overarching themes: practical and structural barriers, knowledge barriers, scientific barriers, and regulatory barriers (Fig 3). Thematic analysis. Practical and structural barriers Practical and structural barriers Participants described both practical and structural barriers to preregistration of their studies. Regarding practical barriers, they identified bureaucratic burden (n = 107), the time needed for preregistration (n = 81), the costs and delays preregistration might entail (n = 26), and a lack of resources (n = 5). Concerns were also raised about the risk of being scooped (n = 72), confidentiality issues (n = 10), and worries about external complaints and harassment (n = 10), as well as incompatibility with industry practices and patenting (n = 5). Structural barriers included the lack of interest (n = 31), the absence of requirements from institutions, journals, or funders (n = 28), as well as a lack of incentives or feedback mechanisms related to preregistration (n = 8). In some cases, researchers reported limited support from co-authors and research partners for preregistration (n = 2), while others were not in the position to make the decision themselves (n = 8). Knowledge barriers Knowledge barriers Many participants stated that they were not aware that preregistration even existed (n = 76), while some were just unfamiliar with the procedure, describing a lack of guidance or uncertainty about the steps involved and the appropriate platforms for their studies (n = 7). Others, however, expressed general skepticism about the potential benefits and overall impact of preregistration (n = 42). Scientific barriers Scientific barriers Many participants working in basic or experimental research questioned the suitability of their studies for preregistration based on the unpredictability and need for flexibility of their research (n = 74). Several of them emphasized the frequent need to deviate from initial methodological plans as part of the iterative nature of their research programs (n = 27), which for them seems incompatible with preregistration. Others raised more general concerns that preregistration limits flexibility (n = 48), compromises innovation (n = 20), and stifles creativity (n = 14). Regulatory barriers Regulatory barriers A main issue under regulatory barriers was the country’s highly controlled research environment that limits animal research (n = 22) and reduces international competitiveness (n = 18). Others more generally stated the overregulation of animal research in Switzerland (n = 16), and some participants even expressed concerns that additional interventions, such as (mandatory) preregistration, could lead Swiss animal researchers to relocate to countries with more permissive regulations (n = 16). Quantitatively assessed barriers Quantitatively assessed barriers Apart from the open-ended items, barriers to preregistration were also assessed using two closed-ended items: one administered to participants with and one to participants without preregistration experience. The responses to the closed-ended items reflected the patterns identified through thematic analysis. Participants who had never preregistered before chose bureaucratic burden (77.6%), time costs (71.4%), and low flexibility (65.7%) as the most common barriers to preregistration (Fig 4). Additionally, more than half also indicated concerns of being scooped (53.8%) and the inability to make necessary changes to their study protocol (52.4%) as important barriers (Fig 4). Similarly, the problems most frequently encountered by those with preregistration experience were bureaucratic burden (60%), time costs (40%), insecurity about what to include in the preregistration (33.3%), limited flexibility during analysis (26.7%), and being prevented from making necessary changes to the study protocol (20%) (Fig 4). Overall, the concerns expressed by participants without preregistration experience were mirrored by the problems reported by those with preregistration experience, but the rates of concerns by the inexperienced participants were much higher than the rates of problems encountered by the experienced participants. Barriers to preregistration. n, subgroup sample size. The data required to generate this figure can be found at https://doi.org/10.48620/98470. Facilitators (Aim 4). When asked about the benefits of preregistration, up to 140 participants described various advantages of the practice (S6 Table). These perceived benefits could serve as motivators for adopting preregistration in the future. Three main themes emerged from the thematic analysis: transparency and integrity drivers, collaboration and protection of intellectual property, and practical and contextual incentives (Fig 3). However, while some participants recognized these advantages, many saw no benefits at all (n = 55), or only for confirmatory studies (n = 12). Transparency and integrity drivers Transparency and integrity drivers Despite the mainly negative perception overall, some participants pointed out that preregistration could promote transparency in science (n = 30), increase credibility and trustworthiness (n = 7), and support the Open Science movement (n = 4). Others highlighted its role in reducing redundant parallel research (n = 10) and contributing to a better public understanding of research (n = 9). Besides benefits to transparency and openness, participants mentioned the potential to promote research rigor and scientific integrity. Some argued that it could generally improve research quality (n = 19) or the reliability and reproducibility of research findings (n = 10). Others noted more specifically that it could lead to better methodological planning and study design (n = 15), improve statistical analysis (n = 5), or promote uniformity of experimental protocols (n = 7) and fewer deviations (n = 3). Others saw benefits in preventing questionable research practices (n = 8), such as HARKing (n = 5) and p-hacking (n = 4), or in reducing publication bias (n = 16) or researcher bias (n = 2). Furthermore, a few participants mentioned better consideration of the 3Rs of animal use (n = 8). Collaboration and protection of intellectual property Collaboration and protection of intellectual property Participants also described collaboration-related benefits of preregistration. Some pointed out that preregistration may encourage scientific feedback and exchange (n = 16), while others described its potential to foster collaborations and synergies (n = 2). In addition, preregistration was seen by some as providing a clear track record of the studies, which could help protect researchers’ intellectual property (n = 6). Practical and contextual incentives Practical and contextual incentives Finally, participants mentioned some practical and contextual incentives related to preregistration that might facilitate its future use. Some highlighted the improved time and project management, which they attributed to better study planning required for preregistration (n = 19). A few noted that it may help with drafting papers and even speed up the journal review process, as parts of the manuscript are already written during the preregistration phase (n = 2). Suggestions (Aim 5). Up to 137 participants responded to the open-ended items regarding suggestions for improving preregistration (S7 Table). The following overarching themes emerged from the thematic analysis: practical and structural recommendations, education and awareness, and incentives (Fig 3). Practical and structural recommendations Practical and structural recommendations Participants offered a wide range of practical and structural recommendations to adapt the preregistration process to the Swiss context. They suggested the implementation of an easy-to-use tool with a clear, yet flexible, template (n = 34) and emphasized the need to make changes after preregistration (n = 18). Some proposed linking this tool to the legal authorization procedure for animal studies (n = 29). Strong confidentiality measures were also recommended (n = 16) and extending the embargo period to more than five years (n = 4). In addition, participants asked for institutional support and resources, such as dedicated staff and funding (n = 8), and highlighted the value of receiving expert feedback on the preregistered studies (n = 6). A few participants called for international rather than national implementation of preregistration (n = 3). Furthermore, several participants advocated for preregistration to remain voluntary in Switzerland (n = 11), and if made mandatory, to restrict it to confirmatory studies (n = 6). Education and awareness recommendations Education and awareness recommendations To facilitate the adoption of preregistration in Switzerland, participants described a need for more knowledge and awareness (n = 27). Specifically, they requested information on where and how to preregister (n = 13), access to workshops, courses, or continued education options (n = 11), and concrete examples of preregistered studies (n = 1). Importantly, however, many participants emphasized the importance of proof that preregistration is beneficial across all types of research, including basic and exploratory studies (n = 34). Incentive recommendations Incentive recommendations Principal investigators, institutions, funders, journals, and the scientific community were identified as essential in fostering the practice of preregistration (n = 28). Several participants noted that endorsement or requirement from these parties would legitimize preregistration in animal research. Participants also listed a series of incentives that could encourage researchers to preregister, including a faster authorization procedure for animal studies, benefits from funding organizations, or publishing advantages (n = 16). Discussion With this survey, we aimed to evaluate animal researchers’ experience with, and perspectives on, preregistration in animal research. To this end, we assessed psychosocial constructs related to preregistration among animal researchers, using the population of animal study directors accredited in Switzerland as a study population. To our knowledge, this is the first study to examine psychosocial constructs related to preregistration among animal researchers. Previous work has examined preregistration in animal research through qualitative stakeholder analyses of implementation barriers [53] and survey-based studies of perceived strengths and weaknesses among animal researchers [37]. In contrast, the present study provides a structured assessment of psychosocial factors related to preregistration, informed by the Theory of Planned Behavior, by examining key components such as attitudes, perceived social norms, perceived behavioral control, and related barriers and experiences. General experiences We found that almost half of the participants were unaware of preregistration, and only 10% had preregistered a study before. These results are in stark contrast to a recent survey on preregistration in psychology in Germany [40], where only 4% of participants had never heard of preregistration, and 62% had preregistered at least one study in the past. Similarly, a further survey conducted in the Netherlands reported that 43% of researchers across all research fields had prior experience with preregistration [54], while studies from behavioral and social sciences found rates of approximately 20% [55,56]. Although these differences may be partly explained by sampling biases inherent to the convenience samples of previous studies, our findings suggest that awareness of, and experience with, preregistration are rather limited among animal researchers. Interestingly, motivation for first-time preregistration also differed across studies. In our sample, almost half of the participants indicated that they had preregistered because it was mandatory for a project, while only one-third was self-motivated. By comparison, in the German study on researchers in psychology, 49% had preregistered voluntarily, and only 13% reported having preregistered because it was mandatory. This suggests that enforcement, rather than an intrinsic motivation, led Swiss animal researchers to preregister. In line with this, nearly half of the participants indicated that institutional policies would influence their decision to preregister in the future. However, almost a third stated that nothing could affect their decision. Our findings therefore suggest that policy changes may hold the greatest potential in promoting preregistration among animal researchers, but the widespread resistance within the research community should be considered when developing and implementing new policies. Psychosocial constructs and associations On average, participants showed negative perceptions on all psychosocial constructs assessed here. They exhibited rather negative attitudes toward preregistration, perceived social norms as discouraging preregistration, and indicated limited abilities for preregistration in terms of both resources and knowledge. Once again, our results differ from those described in other disciplines and countries, where preregistration was typically perceived and evaluated rather positively [40,56,57]. Furthermore, both the intention and motivation to preregister future studies were low in our sample, while obstacles to preregister were perceived as relatively high. These findings indicate that animal researchers are reluctant to engage in preregistration and perceive the barriers to do so as substantial. However, participants with prior preregistration experience held more positive views of preregistration compared to those who had never preregistered before, a pattern also observed in the field of psychology [40,57]. In contrast, the longer participants had worked in animal research, the more negative their perceptions of preregistration were. This is in line with evidence from behavioral science and psychology, where more experienced researchers showed greater reluctance toward preregistration [40,56]. Taken together, our findings reveal substantial resistance and little support for preregistration within the Swiss animal research community, particularly among researchers without preregistration experience and more senior researchers. Future efforts to promote preregistration should therefore tailor their approach to target these critical subgroups. Although no significant associations of gender and organization of employment were observed for any other Scale or Subscale, they both differed in the researchers’ perceived ability to preregister. Thus, female researchers and participants employed in the private sector rated their knowledge required for preregistration lower than male researchers and those working in academia. These findings may suggest potential structural differences in animal researchers’ capacities to preregister, with women and industry researchers perceiving themselves less equipped to engage in preregistration. However, the gender difference could also reflect that men tend to overestimate their knowledge more often than women, suggesting that women’s lower ratings may indicate more accurate or honest self-evaluations rather than a true lack of capacity [58]. Lastly, the field of animal research in which participants were active was also associated with differences in perceptions of preregistration. Researchers from General Biology (including areas such as animal behavior, nutrition, ecology and zoology) reported more favorable perceptions of and less competitive obstacles regarding preregistration than biomedical researchers. Whether this indicates that General Biology is perceived as less competitive, resulting in less fear of being scooped compared to basic and applied biomedical research is not clear. However, disciplinary differences should be considered when allocating resources toward fostering preregistration among animal researchers. Barriers and facilitators The most common practical and structural barriers identified by participants without preregistration experience included bureaucratic burden, excessive time investment, restricted flexibility, and challenges related to implementing necessary modifications to study plans. These findings are consistent with previous qualitative work identifying similar concerns among animal research stakeholders [53], as well as with evidence from psychology [40], where comparable barriers have been observed, suggesting that these issues are shared across disciplines. Notably, in our study, anticipated barriers among participants without preregistration experience exceeded the actual problems reported by those who had preregistered. This discrepancy indicates a gap between perceived and actual barriers to preregistration, likely stemming from assumptions rather than practical realities of preregistration. Moreover, several concerns reported by participants without preregistration experience reflect common misconceptions, such as the assumption that deviations from a preregistered study plan are not allowed or discouraged. In fact, preregistration has been described as a “plan, not a prison”, recognizing the need for deviations when they are justified and transparently reported [59]. Methodological guidance on when and how to deviate from preregistered study plans is available, demonstrating that deviations are part of preregistered research [41,60]. The same is true for the fear of being scooped. In fact, preregistration protects against scooping, as it provides a time stamp to a research idea much earlier in the process, and by putting the preregistered study plan under embargo until the findings have been published prevents scooping of research ideas. Such misconceptions are concerning, as they contribute to unfavorable attitudes towards preregistration and prevent researchers from engaging with it. Targeted education for animal scientists may help address some of these perceived barriers and correct misconceptions. At the same time, it is paramount to acknowledge the existing administrative burden and the regulatory pressure faced by the animal research community in Switzerland and elsewhere. Our analysis suggests that some animal researchers perceive preregistration as redundant given the existing authorization procedure for animal experimentation, and the majority expressed concerns about the additional administrative burden that preregistration would entail. This may also reflect the general frustration and pressure experienced by Swiss animal scientists with the current system, which may contribute to the negative attitudes towards preregistration as it is perceived as an additional administrative layer within an already very bureaucratic process. It is, therefore, important to emphasize that preregistration does not duplicate the authorization procedure but serves a complementary purpose. While the authorization procedure is legally mandated and serves ethical approval and implementation of the 3R principle, preregistration aims to foster transparency and scientific rigor of animal research. Before implementing new policies, authorities should be mindful of the research context and of the potential resistance such changes may raise. In addition to practical and structural barriers, several participants indicated that preregistration is incompatible with the unpredictable, iterative nature of discovery-oriented, exploratory research. Although preregistration is arguably more straightforward in the case of a confirmatory study with a clearly defined hypothesis, it is another common misunderstanding that preregistration cannot be used for exploratory research. Exploratory research generates preliminary evidence and hypotheses that stimulate further avenues of research [61]. It is thus in the best interest of the scientific community that exploratory research is trustworthy and useful [62]. Again, this perceived barrier might be addressed by educating animal researchers about existing flexible preregistration templates (e.g., AsPredicted, OSF) that support preregistration of specific types of research. Apart from the barriers to preregistration, participants also acknowledged a range of potential benefits, which may serve as motivators for its adoption. Participants saw value in preregistration for promoting transparency, improving study design and fostering scientific integrity. Some also noted its potential to mitigate publication bias, enhance research quality and support better consideration of animal use. Similar perceived benefits, particularly regarding transparency, research quality, and reduction of publication bias, have been highlighted in previous work in animal research [37,53]. Emphasizing the role of preregistration in addressing questionable research practices and the overall contribution to scientific rigor might help motivate researchers for preregistration. Taken together, the barriers and facilitators as currently perceived by the animal research community highlight the complexity of implementing preregistration in animal research. Addressing misconceptions, emphasizing the benefits, and providing support for targeted problems may help reduce resistance and facilitate adoption of preregistration among animal researchers. Suggestions Participants provided a wide range of recommendations for improving and facilitating preregistration. Among practical aspects, they highlighted the need for a clear and flexible template, strong confidentiality measures, additional funding, specialized support staff, and integration of preregistration with the authorization procedure for animal experimentation to avoid duplication and unnecessary bureaucratic burden. Moreover, participants stressed the importance of keeping preregistration voluntary. These suggestions underline the need to adjust policies and procedures of preregistration to the specific research context (e.g., the existing authorization procedure for animal experiments) to facilitate uptake among scientists. Given the limited knowledge about preregistration within the animal research community, participants also emphasized the need to increase awareness and offer education and training. Similar to findings in behavioral science [56], participants expressed uncertainty about the benefits of preregistration and highlighted the importance of evidence demonstrating that preregistration improves scientific quality. In addition, participants indicated a preference for concrete incentives to encourage preregistration, such as preregistration accelerating the authorization procedure, funding benefits, and publishing advantages. Thus, besides offering appropriate education and training, as well as institutional support for preregistration, providing adequate infrastructure might be key for scaling up the use of preregistration in animal research. This could entail aligning the application form for the authorization of animal experiments with a preregistration template to avoid duplication and facilitate automatic transfer of relevant content to the preregistration template. Strengths and limitations A major strength of this study lies in the clearly targeted study population and the high response rate, with nearly one-third of all accredited study directors of animal experiments in Switzerland participating in the survey. Unlike previous studies, which were typically based on convenience samples and thus less representative of their target populations, our survey reached the entire population of accredited study directors. Based on the available socio-demographic and professional characteristics, we did not detect any differences between study participants and non-participants that would indicate selection biases. Taken together, these aspects suggest that our study sample was representative of our target population. Nonetheless, because only a limited set of variables could be compared between participants and non-participants, some caution may be warranted when extending our findings to the overall population of animal study directors in Switzerland. Moreover, our decision to target study directors was based on the fact that they are the ones who decide whether or not to preregister a study, while other personnel involved in animal experiments (animal care staff, attending veterinarians, technicians, and students) may have different views but do not usually have the power to decide on whether or not to preregister a study. Therefore, our findings may not necessarily generalize to all personnel involved in animal research. However, given the international nature of the Swiss animal research community and the observation that research communities often vary more by field than by country, the patterns described in this study may be informative beyond the Swiss context. Particularly for countries with regulatory structures similar to those in Switzerland, such as the countries within the European Union, our findings may provide useful guidance for fostering preregistration in animal research. Another important strength of the study is its mixed-methods design. The use of both closed-ended and open-ended measurements allowed for a deeper and more nuanced understanding of the studied constructs, which should enhance the robustness of our findings. Apart from these strengths, the following limitations of the study should be considered. First, despite the high response rate and the apparent similarity between participants and non-participants, our sample might still suffer from some selection bias. For example, individuals with particularly strong opinions about preregistration may have been more likely to participate in the study, leading to a skewed distribution of responses, towards both more negative and more favorable evaluations of preregistration. However, given that almost 40% of the participants had never heard of preregistration prior to the survey, it seems unlikely that such strong views were predominant, suggesting that selection bias may be limited. Second, despite being introduced to the definition of preregistration at the beginning of the survey, some participants may not have read or fully understood the concept and may have confused preregistration with the mandatory authorization procedure required to obtain a license for an animal experiment in Switzerland (animex-ch). Such misunderstanding would likely bias the results toward an overestimation of preregistration experience and further reduce the proportion of participants with actual preregistration experience in our sample. This is supported by requests received after survey completion from three participants who asked to have their data deleted upon realizing that they had confused the two concepts. Finally, we do not know whether participants with preregistration experience had preregistered preclinical animal studies or clinical human studies, which may again lower the proportion of those with actual preregistration experience in animal research. If preregistration experience was derived from clinical human research, these participants may not have encountered the specific challenges associated with preregistering animal studies. As a result, their responses may be more similar to those of participants who never preregistered, thereby attenuating observed differences between groups. As almost half of the participants indicated that their first preregistration was carried out because it was mandatory for a project, it is plausible that these cases refer to clinical human studies where preregistration is mandatory. Nevertheless, this may not compromise our conclusions, as the underlying concept and purpose of preregistration—namely transparency on the design, conduct, analysis, and reporting of research—is the same across both research domains. Conclusions Preregistration is arguably among the most impactful practices promoted by the Open Science movement. While it has long been established as standard practice in human clinical trials [17] and is increasingly taken up in other fields of research [55], preregistration has not been widely adopted in animal research. Given the limited knowledge of preregistration among animal scientists in Switzerland, as revealed by this study, targeted educational initiatives that clarify the purpose of preregistration, address common misconceptions (e.g., regarding flexibility, deviations, and scooping), and provide guidance on how to preregister studies are necessary before the research community would consider adopting preregistration on a wider scale. The widespread skepticism and resistance among specific subgroups of researchers—particularly those with no prior preregistration experience, greater research seniority, and those working in biomedical research—highlight the need for strategies tailored to the specific concerns of these groups. For example, educational efforts may be particularly important for animal researchers who never preregistered studies, while senior researchers and those working in the biomedical field may benefit from discipline-specific examples demonstrating how preregistration can be integrated into discovery-driven, exploratory research. Addressing key concerns, such as the bureaucratic burden and time constraints faced by animal researchers, may further require structural support, such as user-friendly preregistration templates, integration of the authorization procedure with preregistration, clear institutional guidelines, and administrative support for preregistration. Finally, implementing incentives (e.g., publication and funding benefits, recognition in research assessments) that recognize preregistration and transparent reporting may help foster engagement. Taken together, these measures would represent essential steps toward the successful implementation of preregistration in Switzerland and possibly elsewhere. Supporting information Codebook of all survey items used in the study and differences from those used by Spitzer and Mueller (2023). (XLSX) Psychometric properties of the analyzed scales and subscales. (DOCX) Comparison of preregistered and non-preregistered analyses. (DOCX) Attention check item. (DOCX) Deviations from the preregistered analysis plan. (DOCX) Results on general experiences with study preregistration. (DOCX) Subsample comparison of demographic characteristics between participants with and without preregistration experience. (DOCX) Statistics on the multivariate and univariate effects reported for each predictor separately. (DOCX) Overview of qualitative codes – Barriers. (DOCX) Overview of qualitative codes – Facilitators. (DOCX) Overview of qualitative codes – Suggestions. (DOCX) 10 Oct 2025 Dear Dr Würbel, Thank you for submitting your manuscript entitled "Researchers‘ perspectives on preregistration in animal research" for consideration as a Research Article by PLOS Biology. Your manuscript has now been evaluated by the PLOS Biology editorial staff, as well as by an academic editor with relevant expertise, and I'm writing to let you know that we would like to send your submission out for external peer review. IMPORTANT: Please change your article type to "Meta-Research Article" when you upload your additional metadata (see next paragraph). However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire. Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. After your manuscript has passed the checks it will be sent out for review. To provide the metadata for your submission, please Login to Editorial Manager (https://www.editorialmanager.com/pbiology) within two working days, i.e. by Oct 14 2025 11:59PM. If your manuscript has been previously peer-reviewed at another journal, PLOS Biology is willing to work with those reviews in order to avoid re-starting the process. Submission of the previous reviews is entirely optional and our ability to use them effectively will depend on the willingness of the previous journal to confirm the content of the reports and share the reviewer identities. Please note that we reserve the right to invite additional reviewers if we consider that additional/independent reviewers are needed, although we aim to avoid this as far as possible. In our experience, working with previous reviews does save time. If you would like us to consider previous reviewer reports, please edit your cover letter to let us know and include the name of the journal where the work was previously considered and the manuscript ID it was given. In addition, please upload a response to the reviews as a 'Prior Peer Review' file type, which should include the reports in full and a point-by-point reply detailing how you have or plan to address the reviewers' concerns. During the process of completing your manuscript submission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit http://journals.plos.org/plosbiology/s/preprints for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF. Feel free to email us at plosbiology@plos.org if you have any queries relating to your submission. Kind regards, Roli Roberts Roland Roberts, PhD Senior Editor PLOS Biology rroberts@plos.org 12 Dec 2025 Dear Dr Würbel, Thank you for your patience while your manuscript "Researchers‘ perspectives on preregistration in animal research" was peer-reviewed at PLOS Biology. It has now been evaluated by the PLOS Biology editors, an Academic Editor with relevant expertise, and by three independent reviewers. You'll see that reviewer #1 says that the study is “an important contribution” but he wants you to be less enthusiastic about preregistration in the paper, to flag the limitations of some of your analyses, and present the analysis of psychological scales much more clearly (including an additional Fig). Reviewer #2 is impressed by the dataset, but suggests several ways in which the analysis and presentation could be much clearer, and cautions you to avoid causal wording. Reviewer #3 liked your transparency, but raises a number of concerns, including an undeclared deviation from the preregistration, failure to correct for multiple testing, a request for more concrete recommendations, and a query about separating respondents who had not heard of registration. I see that two reviewers noted that the data DOI does not currently resolve; this must be rectified. In light of the reviews, which you will find at the end of this email, we would like to invite you to revise the work to thoroughly address the reviewers' reports. Given the extent of revision needed, we cannot make a decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is likely to be sent for further evaluation by all or a subset of the reviewers. In addition to these revisions, you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests shortly. We expect to receive your revised manuscript within 3 months. Please email us (plosbiology@plos.org) if you have any questions or concerns, or would like to request an extension. At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not intend to submit a revision so that we may withdraw it. **IMPORTANT - SUBMITTING YOUR REVISION** Your revisions should address the specific points made by each reviewer. Please submit the following files along with your revised manuscript: 1. A 'Response to Reviewers' file - this should detail your responses to the editorial requests, present a point-by-point response to all of the reviewers' comments, and indicate the changes made to the manuscript. *NOTE: In your point-by-point response to the reviewers, please provide the full context of each review. Do not selectively quote paragraphs or sentences to reply to. The entire set of reviewer comments should be present in full and each specific point should be responded to individually, point by point. You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response. 2. In addition to a clean copy of the manuscript, please also upload a 'track-changes' version of your manuscript that specifies the edits made. This should be uploaded as a "Revised Article with Changes Highlighted" file type. *Re-submission Checklist* When you are ready to resubmit your revised manuscript, please refer to this re-submission checklist: https://plos.io/Biology_Checklist To submit a revised version of your manuscript, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' where you will find your submission record. Please make sure to read the following important policies and guidelines while preparing your revision: *Published Peer Review* Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details: https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/ *PLOS Data Policy* Please note that as a condition of publication PLOS' data policy (http://journals.plos.org/plosbiology/s/data-availability) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5 *Blot and Gel Data Policy* We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements *Protocols deposition* To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments. Sincerely, Roli Roberts Roland Roberts, PhD Senior Editor PLOS Biology rroberts@plos.org ------------------------------------ REVIEWERS' COMMENTS: Reviewer #1: [identifies himself as Ulf Toelch] Priboi et al. present in their manuscript "Researchers' perspectives on preregistration in animal research" a valuable survey results on the perception of preregistration of animal researchers in Switzerland. The presented data is an important contribution that will inform policy not only in Switzerland and beyond. To increase the impact, the authors may consider my comments below. The study is complex including a preregistration and many supplemental tables. I apologise to the authors that I could not assess the whole material. Time given for review times at PLOS Biology are extremely short and reviewers who contribute their time for free are constantly harassed with emails about the status of their review. In the short time allowed, I was not able to do an in depth comparison of the preregistration and the actual manuscript. This already shows that for preregistrations to become useful also publisher and editors need to allow for slower but more rigorous science. Value of preregistration The authors start with the slight overstatement that preregistration is impactful and at the same time acknowledge that evidence backing this claim is not conclusive yet (ll62/63). Animal researchers already preregister their study with regulatory authorities even though this may not be as exhaustive as a formal preregistration and not include all the details. It is unclear in particular in the discussion what a formal preregistration would add to the animal permits. With the negative attitudes displayed by researchers how does this connect to the thematic analysis what researchers want and how realistic are these demands? Overall, the manuscript would benefit from a less enthusiastic description of preregistration as the panacea to problems in animal research. Comparison of participants and non participants. The authors compare study participants to non participants. This is done via t-tests and an absence of significance is interpreted as similarity between groups. There is good evidence that such an approach is not optimal (Table 1 fallacy). If the authors are interested in confounders or selection bias, the three comparions described here are insufficient to conclude that study populations were similar in the sense that results here will generalise to the general population of study directors. This should be acknowledged in the discussion. The authors may want to consider removing p-values in the comparison of the two groups. Psychological scales The scales are analysed in much detail. The reader is, however, lost in numbers. A Figure summarising some of the scale results would be beneficial to get a better grasp of magnitude of effects. Also there are multiple comparisons and only on some scales there are differences for example for gender. This leads to meaningless comparisons such as: "Follow-up pairwise comparisons (S7 Table) revealed that participants who preferred not to state their gender reported significantly less positive attitudes and lower motivations to preregister than participants identifying as female or male;" (ll409-411) This is based on a comparison of 14 particpants vs the rest of the population. I doubt that based on this can claim that these differences exist. The reported comparisons should be evaluated carefully by the authors. That said, in the current form I feel it is difficult to see the overall picture. The results are presented in a way that makes it hard to grasp what the data looks like. Maybe supplementary tables contain this information but I was not able to assess these (see comment above). An additional Figure and a more selective presentation of the psychological scale results could facilitate a better understanding of the material provided. Reviewer #2: [identifies himself as Andrew H. Tyner] In "Researchers' perspectives on preregistration in animal research," the authors adapt a questionnaire from Spitzer and Mueller (2023) to explore attitudes, norms, and experiences with preregistration among a sample of Swiss study directors working in animal research. The authors present their data in rich detail through psychometric analyses of closed-ended items and a thoroughgoing exploration of themes emerging from the open-ended items. I concur with the authors on the importance of gaining a deeper understanding of researchers' experiences with preregistration and I commend them for their impressively high response rate and the care and detail of their analyses. Below I offer a set of suggestions to improve the presentation of the research and extract more meaning out of these data. Major Comments 1. The authors rely heavily on significance testing, particularly in Aim 3, to the exclusion of substantive interpretations of their findings and descriptively meaningful results. My main takeaway from Aim 3 is that many of these variables have statistically significant associations, many others do not, and I'm not left with any clearer understanding of what these findings tell us about challenges, opportunities, or understandings of preregistration in their sample. The supplemental materials aren't much help either - for example, in the 'Field of research' analyses the authors refer readers to Table S8, but this table (like Tables S7 and S9) only shows results on the transformed scales. What am I to make of the fact that basic and experimental medical researchers have a mean of -0.47 on the attitudes scale, while basic biological researchers have a mean of -0.70 and general biologists have a mean of -0.12? I understand that the authors are making use of the scales they developed in Aim 2, but for a general audience the authors need to be translating at least some of these results into substantively meaningful terms. I would encourage the authors to make greater use of visualizations in this manuscript to highlight some of the key relationships they see emerging in their data. In some situations these visualizations might make use of the underlying items to complement the presentation of scales. 2. As a related concern, the MANCOVA models presented in Aim 3 need a more careful presentation and justification. To start with, the authors should remove any language referring to effects (e.g. "A MANCOVA was conducted to examine the effects of preregistration experience, animal research experience, gender, field of research, and organization of employment on the eight Preregistration Scales and Subscales" [371-373]). These are not causal models and the data they've collected do not lend themselves to a causal analysis or interpretation. What's more, the setup of the models doesn't follow an intuitive causal ordering - they've set up the preregistration scales as the outcome variables and included preregistration experience as a predictor. The picture is undoubtedly more complicated than attitudes/norms affect behaviors, but a model where the behaviors are a primary predictor for the psychometric outcomes seems even more questionable. At the very least we'd think of behavior/experience and attitudes/norms as mutually influencing each other. Again, all of this language of causal ordering and effects is misplaced given the structure of these data - the real takeaway is that many of these predictors and constructs are statistically related. But, if the authors are going to present their findings in causal terms and set up models with predictors and outcomes, it should be done more carefully. 3. The presentation of the open-ended results in Aims 4 and 5 is impressively thorough. Still, I wonder whether these results could be better summarized or organized to distill key insights and takeaways for the reader. As it stands, these sections often read like the authors are just relaying all of the open-ended responses they received. The section on Knowledge Barriers stands out as an example: "Many participants stated that they were not aware that preregistration even existed. Some were unfamiliar with the procedure, describing a lack of guidance or uncertainty about the steps involved and the appropriate platforms for their studies. Others expressed general skepticism about the potential benefits and overall impact of preregistration in science" (471-474). Help the reader navigate these findings - what percentage of researchers expressed these views? Does that vary by relevant background characteristics? What do we learn from this that we didn't get from the close-ended items? And then a few lines later in the next section: "Often, participants working in exploratory or fundamental research questioned the feasibility of preregistration for their studies" (477-478). What does often mean? What does questioning the feasibility mean? And "However, while some participants recognized these advantages, many saw no benefits at all, or found it appropriate only for confirmatory studies" (493-495) - why such imprecision in reporting? Who holds these beliefs and in what proportions? 4. Finally, I was not able to access this manuscript's data since the provided DOI did not resolve (https://doi.org/10.48620/91802). The authors mention that the files are currently under review by the team managing University of Bern's repository, so perhaps that's the reason. All the same, reviewers should have an opportunity to reproduce the authors' analyses as a matter of course. Minor comments 5. The authors explain their revised analytical approach in item 3 of Table S1. They write that they switched from simple and multiple linear regressions to a MANCOVA approach because of multi-category predictors. I agree with the authors that MANCOVA is an advisable approach here but not for the reasons the authors offer. The advantage of MANOVA/MANCOVA (and multivariate analyses more generally) is the simultaneous estimation of models with distinct but correlated outcome variables. It doesn't have anything to do with multi-category predictors. You can fit multiple linear regressions with multi-category predictions without a problem - like binary predictors, one level becomes the reference and the results of the other categories are interpreted in light of that reference category. 6. "Preregistration is a promising tool for improving transparency and quality of research, and is arguably among the most impactful Open Science practices" (lines 56-58). I'd soften this language to, "...and arguably has the potential to be among the most impactful…" The evidence base on preregistration is not strong enough yet to justify the statement as written (as the authors point out elsewhere in the manuscript). 7. "The inability to replicate published results…have questioned…" (lines 68-69". Rephrase to, "...have led to questions…" 8. "...these questionable research practices can slow down scientific progress, waist animal lives for inconclusive results…" (lines 78-79). Should be "...waste animal lives…" 9. "The values for non-participants are FSVO-provided data, whereas those for participants are based on survey responses. This distinction arises because FSVO collected gender data using only two categories (female, male), while our survey allowed for four options (female, male, other, and prefer not to say)" (lines 295-297). I'd recommend that the FSVO-provided data be used for both groups in the Table 1 reporting. Otherwise the data aren't directly comparable. 10. "Taken together, these results suggest that participants and non-participants were comparable in terms of age, gender distribution, and animal research experience" (lines 318-320). I'd recommend a more constrained interpretation here to avoid conflating absence of evidence with evidence of absence. Perhaps something like: "Altogether we do not find statistically significant differences between participants and non-participants in terms of age, gender distribution, or animal research experience." 11. "Similarly, a further survey conducted in the Netherland…" (566). Should be "...in the Netherlands…" 12. "We can only speculate that these participants may have had negative experiences with preregistration and/or may have high privacy concerns that leaves them in general reluctant to disclose information, being it research ideas or private information such as their gender" (615-618). Even as the authors acknowledge that this is speculative, I find this explanation nonsensical. The reasons participants have for not disclosing their gender identities are the same reasons they don't preregister? This is implausible and frankly needless - I see it as a consequence of the over-reliance on significance testing. The authors had no reason to expect this significant result in the first place and consequently offer a haphazard interpretation of it - this is a recipe for capitalizing on noise. 13. "This delimitation could help reduce research waste by avoiding repetition and support the refinement of future studies, contributing to overall less animals use" (650-652). I had trouble following this sentence. Consider a rephrase for clarity. 14. "Second, despite being introduced to the definition of preregistration at the beginning of the survey, some participants may not have read or fully understood the concept...This is supported by requests received after survey completion from three participants who asked to have their data deleted upon realizing that they had confused the two concepts" (708-715). Kudos to the authors for this level of transparency. I agree that it's a concern (if three people wrote in with this request there's a good chance that others were also confused), but there's not much to be done about it now. So mostly I just want to thank the authors for the transparent reporting. I think it strengthens the overall credibility of the manuscript and demonstrates exemplary reporting. Best regards, Andrew Tyner Principal Research Scientist Center for Open Science andrewtyner@cos.io Reviewer #3: [identifies himself as Olmo van den Akker] Please find my review in the attached file, and good luck with any revisions! [unformatted version; see attachment for formatted version]: Review of the manuscript titled “Researchers‘ perspectives on preregistration in animal research” submitted to PLOS Biology Reviewer: Olmo van den Akker In this manuscript, the authors surveyed study directors of animal experiments in Switzerland to elicit their experiences with and perceptions of the practice of preregistration in animal research. While the survey responses were heterogeneous, a picture emerged of study directors that have limited knowledge and experience with preregistration, which possibly influenced the skeptical attitudes about the practice. I appreciated the high level of transparency provided in this manuscript, especially the way that the authors show how their questionnaire follows from the questionnaire used by Spitzer and Müller, and that the authors also present the available demographic characteristics of the non-participants. Below you can find a list of major and minor points for improvement. Major points for improvement: 1. The DOI provided for accessing the data (https://doi.org/10.48620/91802) is currently inaccessible, presumably because it remains under review. Ensuring public data availability is essential for assessing validity, enabling re-analysis, and facilitating potential inclusion in systematic reviews. 2. The description of the qualitative analysis is minimal. The statement that “recurring themes were identified” does not provide enough detail to assess the analytical rigor. More information on coding procedures, number of coders, consensus strategies, and links between data excerpts and reported findings is needed. 3. The authors preregistered using Cronbach’s α with a cut-off value of 0.70, yet report McDonald’s ω instead and retain (sub)scales with ω < 0.70. These deviations are not included in the preregistration deviation table. The rationale for these changes, and their implications for reliability and validity, should be explained. 4. Multiple statistical tests are conducted without correction for multiple comparisons. The authors should either justify this decision or apply a correction. In line with this, more emphasis on effect sizes is recommended, especially where statistically significant results correspond to very small effect sizes (e.g., η² = 0.01–0.02), as it is unclear whether such effects are meaningful. 5. The authors carry out many statistical tests but do not correct for multiple testing. The authors should convincingly explain why they did not do so or implement a correction for multiple testing that ensures the findings are not merely based on randomness. What could help here is to focus more on effect sizes. These are more informative, especially since there are many cases where associations are statistically significant but effect sizes are low (eta-squared = 0.01 – 0.02). Can these really be interpreted as substantial effects? 6. Some of the obstacles perceived by the participants can be easily rebutted (e.g. that deviations are discouraged or even forbidden). I would like to see the authors do this in their discussion section as it is quite worrisome that such misconceptions about preregistration remain and seem to influence uptake and attitudes. 7. The recommendations offered in the conclusion (infrastructure, education, incentive systems) are very broad. More concrete and actionable suggestions, perhaps tailored to different stakeholders would improve the manuscript’s utility. Example: “Providing the necessary infrastructure, appropriate educational options and a well-designed incentive system might thus help foster the use of preregistration in the animal research community.” 8. To what extent are the results of participants who never heard of preregistration relevant? Shouldn’t they be left out given that they have no insight into the practice, or shouldn’t the sample be split into those who had at least heard of the practice and those who had not? Minor points for improvement: 1. The introduction is quite comprehensive but the authors should acknowledge that there is also research highlighting that preregistration is currently not as effective as it could be. For example, there are observational studies that show that undisclosed deviations are common and that the positive effects of preregistration are not consistently found across studies. 2. A link to more information about Animex-ch would be helpful. 3. “Additionally, one more reminder was issued at the institutional level by the Animal Welfare Officers (AWO). At the time of the study, 49 institutions in Switzerland had designated AWOs” Does this mean that not all directors received an additional reminder? If so, could this have introduced bias into the sample? 4. It is not entirely clear why some (sets of) questions are labeled under psychosocial constructs and others are not. It can be argued that ‘obstacles’ do not really tap into participants’ psychology, while it can equivalently be argued that the perceptions of barriers to preregistration do tap into psychology. It seems the main difference is the way they are measured so maybe the description should focus on that. The authors could be clearer about this and maybe even disregard the term “psychosocial constructs” altogether. 5. The response rate of 30.2% is way higher than what the authors (and myself) expected. Why do the authors think this is the case? Does this have any ramifications for the interpretation of the results? 6. The authors mention in the preregistration that they would first assess the appropriateness of doing a PCA, but they don’t mention the Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy and Bartlett's test of sphericity in the manuscript. It would be good to state whether these ‘tests’ were indeed carried out. 7. The authors use a MANCOVA framework instead of the preregistered linear regressions (and disclose this in the preregistration deviation table). Because these regressions were planned as the most important analyses in the study, I would encourage the authors to do these regressions regardless and present the results in a supplement. I also think it would be good if the authors would discuss the influence this deviation had on statistical power. 8. Why did the authors more comprehensively present Wilks’ Lambda than Pillai’s Trace when presenting the results? A sentence in the manuscript explaining this would be useful. 9. The process for removing items with “poor psychometric properties” should be described in more detail so readers know which items were removed and why. 10. How do the authors reconcile contradictory survey results? For example, that preregistration is seen by some as more time-consuming and by others as less time-consuming, or that preregistration is seen by some as conducive to collaboration and by others as hampering it. 11. “This study represents the first attempt to evaluate the researchers’ experience with, and perspectives on, preregistration in animal research” I don’t think this claim can be made given that the authors cite some references that also do this (e.g., Wieschowski et al., 2020). 12. “However, the gender difference could also reflect that men tend to overestimate their knowledge more often than women, suggesting that women lower ratings may indicate more accurate or honest self-evaluations rather than a true lack of capacity.” This claim requires references 13. Speculation about the negative experiences or privacy considerations of participants who did not disclose their gender seems excessive, particularly given the small number of respondents in this category, and should be moderated. 14. The claim that the sample is representative of all animal scientists in Switzerland is not supported, since study directors constitute a specific subgroup. I think this statement should be reconsidered. 15. The limitation on page 34 is outlined well but I would like to see some more discussion of how this specific limitation could have biased the results. Submitted filename: Review Wurbel.docx 14 Apr 2026 Submitted filename: Response_to_Reviewers.docx 28 May 2026 Dear Dr Würbel, Thank you for your patience while we considered your revised manuscript "Researchers‘ perspectives on preregistration in animal research" for publication as a Meta-Research Article at PLOS Biology. This revised version of your manuscript has been evaluated by the PLOS Biology editors, the Academic Editor and two of the original reviewers. Based on the reviews, we are likely to accept this manuscript for publication, provided you satisfactorily address the remaining points raised by the reviewers and the following data and other policy-related requests. IMPORTANT - please attend to the following: a) We normally like Titles to contain an active verb, plus some idea of the results, so please could you change it to "A survey of researchers' attitudes to preregistration in animal research reveals multiple perceived barriers to adoption" b) Please address the remaining concerns raised by the reviewers. c) Please address my Data Policy requests below; specifically, we need you to supply the numerical values underlying Figs 1, 2ABCDE, 4, either as a supplementary data file or as a permanent DOI’d deposition. I note that you already have an associated BORIS deposition (https://doi.org/10.48620/91802); please could you confirm whether the data and code in this deposition are sufficient to recreate the Figures? (also note the code issues raised by reviewer #2) d) Please cite the location of the data clearly in all relevant main and supplementary Figure legends, e.g. “The data and code required to generate this Figure can be found in "https://doi.org/10.48620/91802". As you address these items, please take this last chance to review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the cover letter that accompanies your revised manuscript. In addition to these revisions, you may need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests shortly. If you do not receive a separate email within a few days, please assume that checks have been completed, and no additional changes are required. We expect to receive your revised manuscript within two weeks. To submit your revision, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' to find your submission record. Your revised submission must include the following: - a cover letter that should detail your responses to any editorial requests, if applicable, and whether changes have been made to the reference list - a Response to Reviewers file that provides a detailed response to the reviewers' comments (if applicable, if not applicable please do not delete your existing 'Response to Reviewers' file.) - a track-changes file indicating any changes that you have made to the manuscript. NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines: https://journals.plos.org/plosbiology/s/supporting-information *Published Peer Review History* Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details: https://plos.org/published-peer-review-history/ *Press* Should you, your institution's press office or the journal office choose to press release your paper, please ensure you have opted out of Early Article Posting on the submission form. We ask that you notify us as soon as possible if you or your institution is planning to press release the article. *Protocols deposition* To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols Please do not hesitate to contact me should you have any questions. Sincerely, Roli Roberts Roland Roberts, PhD Senior Editor rroberts@plos.org PLOS Biology ------------------------------------------------------------------------ DATA POLICY: You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: http://journals.plos.org/plosbiology/s/data-availability. For more information, please also see this editorial: http://dx.doi.org/10.1371/journal.pbio.1001797 Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms: 1) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as 'Supporting Information' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore). 2) Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication. Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels as they are essential for readers to assess your analysis and to reproduce it: Figs 1, 2ABCDE, 4. NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values). Please also ensure that figure legends in your manuscript include information on where the underlying data can be found, and ensure your supplemental data file/s has a legend. Please ensure that your Data Statement in the submission system accurately describes where your data can be found. ------------------------------------------------------------------------ DATA NOT SHOWN? - Please note that per journal policy, we do not allow the mention of "data not shown", "personal communication", "manuscript in preparation" or other references to data that is not publicly available or contained within this manuscript. Please either remove mention of these data or provide figures presenting the results and the data underlying the figure(s). ------------------------------------------------------------------------ REVIEWERS' COMMENTS: Reviewer #1: [identifies himself as Ulf Toelch] The revised version of the manuscript "Researchers' perspectives on preregistration in animal research" by Probi et al. has improved substantially in clarity and is an excellent read with highly relevant analyses regarding the perception and uptake of preregistrations in animal research. Also data and associated meta data have been deposited in an accessible format in an open repository. Some minor points remain that the authors may want to address. 1.In agreement with reviewer #2, the text has been updated to give a less optimistic and now more nuanced view of preregistrations. What remains, however, is the first sentence of the abstract that, in prominent position, advocates preregistrations in manner that is in my opinion not yet backed up by the evidence. Even when adding "potentially" this still is a very strong statement. This is also the case in ll56/57. I again suggest to tone this down even further. Why the nitpicking on a single sentence? The paper will hopefully be used in policy discussions. These discussion will in my opinion not benefit from the strong language used in the paper. Most evidence only comes from related fields like psychology and clinical trials. Even here the evidence is mixed (e.g. outcome switching occurs despite preregistration in clinical trials, papers deviate in an undisclosed way from preregistrations in psychology). More and better evidence is needed to showcase under what circumstances preregistrations make sense and what expected benefits for the scientific system will be. The paper is an important contribution to inform these discussions. A language that signals an openness to these discussion could be helpful. Please take this only as mild nudging and not fundamental criticism of the paper at large. 2.Ll 232 the conventional threshold for equivalence tests needs a reference. I agree that the equivalence test used here is now better suited than a conventional t-test. In my opinion there is not even a need for a test. The need for a sample that is not influenced by a selection bias is not as strong as in a clinical trial. The authors also discuss the possibility of a selection bias. 3. The Figures now represent the underlying data much better. There is a small typo in the text referring to Figure 2 (grater->greater, line 437). L 434 what does modest mean here. You have in the methods indicated low medium and large effect sizes. Please refer to effect sizes in this terminology. Effect sizes were largely small and some were medium. I also do not understand the word consistency here. What would consistency of effect sizes across categories mean? Reviewer #2: [identifies himself as Andrew H. Tyner] Thanks for the opportunity to re-review "Researchers' perspectives on preregistration in animal research". It's clear from the extensive revisions and detailed point-by-point responses that the authors thoughtfully considered all of the feedback they were provided and made sensible decisions on how to address it. I'm comfortable with this manuscript proceeding to publication. Below I outline my one major reservation; a handful of minor substantive suggestions; and a few remaining line-level suggestions. The line numbers I reference are for the version with tracked changes. Major reservation 1. The reproducibility materials are now available at the link the authors provided, which is good to see. Still, I'm not able to reproduce their analyses using these materials. Part of this has to do with file names. In the readme, the data file is called "Preregistration_Study.xlsx", in the actual materials it's called "Preregistration_Study-anonymized_data", and in the R code it's called "PreReg_Study.xlsx". Additionally, "PreReg_Study.xlsx" appears to be the input of the cleaning script, the output of the cleaning script, and the input of the analysis script. I would strongly prefer to see a 'raw' data file that serves as the input to the cleaning script and then an analytic data file that's both the output of the cleaning script and the input of the analysis script. Also, when I try to run the cleaning script by changing the name of the input file, it throws an error at line 418 because it's being asked to drop columns that don't exist. Minor suggestions 2. "In addition, we used a criterion based on the ratio of the first and second eigenvalue of the PCA, as well as omega hierarchical (ωH) from a bifactor model, to assess essential unidimensionality" (lines 281-283). What was the actual criterion? The authors allude it to without defining it. 3. "When necessary, items with poor psychometric properties (low factor loadings and/or low corrected item-total correlations) and weak conceptual alignment were removed, resulting in improved internal consistency and construct validity of each scale" (lines 424-426). Which items were removed? This is the Results section, so they should just report it directly. 4. "Interestingly, our analysis also revealed differences by gender and organization of employment...may indicate more accurate or honest self-evaluations rather than a true lack of capacity" (lines 813-822). On one hand, nothing they include in this paragraph is inaccurate. On the other hand, it seems slightly misleading to highlight these single instances of statistical differences without recognizing that across *most* constructs there were not statistically significant differences for gender or employment. The absence of evidence for differences is, for me, the main takeaway here. 5. "This might be due to the less competitive nature resulting in less fear of being scooped in General Biology compared the more competitive fields of basic and applied biomedical research" (lines 834-837). I am not in the relevant disciplines, so for a general audience I would suggest more context on what makes basic and applied biomedical research more competitive than General Biology. 6. "Although preregistration is arguably more straightforward in the case of a confirmatory study with a clearly defined hypothesis, it is another common misunderstanding that preregistration cannot be used for exploratory research. Again, this perceived barrier might be addressed by educating animal researchers about existing flexible preregistration templates (e.g., AsPredicted, OSF) that support the preregistration of specific types of research" (lines 899-908). I think this slightly misstates the problem. The question isn't *whether* preregistration of non-confirmatory research is possible; it's *why* researchers should do so. The solution here is to foreground the value proposition of preregistration in non-confirmatory research rather than merely showing that it's possible. 7. The particularly high administrative burdens associated with animal research in Switzerland are alluded to a few times without being explicitly defined. For those without the contextual background, what makes the administrative requirements more stringent in Switzerland compared to peer countries? This deserves a paragraph unto itself in the Discussion since it's a factor that potentially limits the generalizability of their findings. Line-level suggestions 8. "On average, participants exhibited rather unfavorable attitudes towards preregistration..." (lines 45-46). Perhaps "reported" rather than "exhibited" here. 9. "Our findings offer guidance on promising measures to enhance acceptance of preregistration among animal researchers, including raising awareness, offering education and training, and facilitating procedures" (lines 50-53). The ending of this sentence is strange. Facilitating which procedures? 10. "A report by the US National Institute of Health working group has recommended..." (lines 97-98). Which working group are they referring to here? 11. "associations of several predictors on the Preregistration Scales..." (line 297). Should probably be "associations of several predictors with the Preregistration Scales...". 12. "However, on all scales and subscales, participants ratings ranged from..." (lines 455-456). Should be "participants' ratings" instead. 11 Jun 2026 Submitted filename: ResponseToReviwers.docx 15 Jun 2026 Dear Hanno, Thank you for the submission of your revised Meta-Research Article "A survey of researchers' attitudes to preregistration in animal research reveals multiple perceived barriers to adoption" for publication in PLOS Biology. On behalf of my colleagues and the Academic Editor, Cilene Lino de Oliveira, I'm pleased to say that we can in principle accept your manuscript for publication, provided you address any remaining formatting and reporting issues. These will be detailed in an email you should receive within 2-3 business days from our colleagues in the journal operations team; no action is required from you until then. Please note that we will not be able to formally accept your manuscript and schedule it for publication until you have completed any requested changes. Please take a minute to log into Editorial Manager at http://www.editorialmanager.com/pbiology/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process. PRESS: We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with biologypress@plos.org. If you have previously opted in to the early version process, we ask that you notify us immediately of any press plans so that we may opt out on your behalf. We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/. Thank you again for choosing PLOS Biology for publication and supporting Open Access publishing. We look forward to publishing your study. Sincerely, Roli Roland G Roberts, PhD, PhD Senior Editor PLOS Biology rroberts@plos.org